{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:42:19Z","timestamp":1792208539668,"version":"4.4.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Despite advances in diagnosis and treatment, locally recurrent rectal cancer (LRRC) remains a complex condition associated with a poor prognosis. This study aimed to evaluate long-term trends in the management of and oncological outcomes for patients with LRRC treated in a Dutch tertiary referral center.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>All consecutive patients with a confirmed diagnosis of a first LRRC undergoing curative-intent surgical resection at our referral center between 2000 and 2023 were retrospectively analyzed. Primary outcomes were trends in overall survival (OS), disease-free survival (DFS), clear (R0) resection rate, and postoperative complication rates. Cumulative sum (CUSUM) analysis was used to visualize changes in these outcomes over time. Secondary endpoints included temporal changes in prognostic factors associated with improved OS and DFS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 560 patients undergoing curative-intent surgical resection were included. Over time, patients presented with more comorbidities (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), more multifocal disease (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001), and synchronous metastasis (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). The R0 resection rate improved from 59% to 78% over the study period (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). CUSUM analyses demonstrated an upward trend in OS and DFS, indicating a cumulative improvement in survival relative to the reference survival probability. In univariable Cox regression, the most recent time period (2018\u20132023) was significantly associated with improved OS (hazard ratio 0.75; 95% confidence interval 0.58\u20130.97;\n                      <jats:italic>p\u2009<\/jats:italic>\n                      =\u20090.030).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over the past two decades, the outcomes of patients undergoing curative-intent treatment for LRRC have steadily improved. This may reflect advances in diagnostics, neoadjuvant therapy, surgical technique and perioperative care, centralization of care, and patient selection.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1245\/s10434-026-20398-6","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T13:03:20Z","timestamp":1787231000000},"page":"10616-10626","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evolution of Prognosis and Management in Curative Treatment of Locally Recurrent Rectal Cancer: A Comprehensive Analysis from 2000 to 2023"],"prefix":"10.1245","volume":"33","author":[{"given":"Fleur E. C.","family":"Vande Kerckhove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davy M. J.","family":"Creemers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evi","family":"Banken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floor","family":"Piqeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stijn H. J.","family":"Ketelaers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. R. J.","family":"Coebergh van den Braak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jip","family":"Tolenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Jan","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grard A. P.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wikke","family":"Setz-Pels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijs R.","family":"van Oudheusden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alette W.","family":"Dani\u00ebls-Gooszen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan G.","family":"van Ravensteijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene E. G.","family":"van Hellemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Sofie E.","family":"Verrijssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heike M. U.","family":"Peulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanne G.","family":"Bloemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"Nederend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm J. T.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus W. A.","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"issue":"7","key":"20398_CR1","doi-asserted-by":"publisher","first-page":"3915","DOI":"10.1245\/s10434-023-13141-y","volume":"30","author":"H Swartjes","year":"2023","unstructured":"Swartjes H, van Rees JM, van Erning FN, Verheij M, Verhoef C, de Wilt JHW, et al. Locally recurrent rectal cancer: toward a second chance at cure? A population-based, retrospective cohort study. Ann Surg Oncol. 2023;30(7):3915\u201324. https:\/\/doi.org\/10.1245\/s10434-023-13141-y.","journal-title":"Ann Surg Oncol."},{"issue":"13","key":"20398_CR2","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/bjs.10645","volume":"104","author":"K Westberg","year":"2017","unstructured":"Westberg K, Palmer G, Hjern F, Nordenvall C, Johansson H, Holm T, Martling A. Population-based study of factors predicting treatment intention in patients with locally recurrent rectal cancer. Br J Surg. 2017;104(13):1866\u201373.","journal-title":"Br J Surg."},{"issue":"2","key":"20398_CR3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/DCR.0000000000000547","volume":"59","author":"W van der Meij","year":"2016","unstructured":"van der Meij W, Rombouts AJ, Rutten H, Bremers AJ, de Wilt JH. Treatment of locally recurrent rectal carcinoma in previously (chemo)irradiated patients: a review. Dis Colon Rectum. 2016;59(2):148\u201356.","journal-title":"Dis Colon Rectum."},{"key":"20398_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102419","volume":"109","author":"MG Fadel","year":"2022","unstructured":"Fadel MG, Ahmed M, Malietzis G, Pellino G, Rasheed S, Brown G, et al. Oncological outcomes of multimodality treatment for patients undergoing surgery for locally recurrent rectal cancer: a systematic review. Cancer Treat Rev. 2022;109:102419.","journal-title":"Cancer Treat Rev."},{"key":"20398_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102736","volume":"127","author":"F Piqeur","year":"2024","unstructured":"Piqeur F, Creemers DMJ, Banken E, Coolen L, Tanis PJ, Maas M, et al. Dutch national guidelines for locally recurrent rectal cancer. Cancer Treat Rev. 2024;127:102736.","journal-title":"Cancer Treat Rev."},{"issue":"8","key":"20398_CR6","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/bjs.9192","volume":"100","author":"Beyond TME Collaborative","year":"2013","unstructured":"Beyond TME Collaborative. Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes. Br J Surg. 2013;100(8):1009\u201314.","journal-title":"Br J Surg."},{"issue":"Suppl 4","key":"20398_CR7","doi-asserted-by":"publisher","first-page":"iv263","DOI":"10.1093\/annonc\/mdy161","volume":"29","author":"R Glynne-Jones","year":"2018","unstructured":"Glynne-Jones R, Wyrwicz L, Tiret E, Brown G, Rodel C, Cervantes A, et al. Rectal cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv263.","journal-title":"Ann Oncol"},{"key":"20398_CR8","unstructured":"PelvEx C. Induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as neoadjuvant treatment for locally recurrent rectal cancer: study protocol of a multicentre, open-label, parallel-arms, randomized controlled study (PelvEx II). BJS Open. 2021;5(3)."},{"issue":"5","key":"20398_CR9","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/cancers14051161","volume":"14","author":"C PelvEx","year":"2022","unstructured":"PelvEx C. Contemporary management of locally advanced and recurrent rectal cancer: views from the PelvEx collaborative. Cancers. 2022;14(5):1161.","journal-title":"Cancers"},{"issue":"18","key":"20398_CR10","doi-asserted-by":"publisher","first-page":"4523","DOI":"10.3390\/cancers15184523","volume":"15","author":"S Nordkamp","year":"2023","unstructured":"Nordkamp S, Creemers DMJ, Glazemakers S, Ketelaers SHJ, Scholten HJ, van de Calseijde S, et al. Implementation of an enhanced recovery after surgery protocol in advanced and recurrent rectal cancer patients after beyond total mesorectal excision surgery: a feasibility study. Cancers. 2023;15(18):4523.","journal-title":"Cancers"},{"issue":"11","key":"20398_CR11","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1111\/codi.17183","volume":"26","author":"S Nordkamp","year":"2024","unstructured":"Nordkamp S, Ketelaers SHJ, Piqeur F, Scholten HJ, van de Calseijde S, Tolenaar JL, et al. Current perioperative care in patients undergoing a beyond total mesorectal excision procedure for rectal cancer: What are the differences with the colorectal enhanced recovery after surgery protocol? Colorectal Dis. 2024;26(11):1903\u201312.","journal-title":"Colorectal Dis."},{"issue":"4","key":"20398_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5114\/jcb.2022.118305","volume":"14","author":"AE Verrijssen","year":"2022","unstructured":"Verrijssen AE, Dries WJF, Cnossen JS, Theuws J, Peulen HMU, van den Berg HA, et al. Narrowing the difference in dose delivery for IOERT and IOBT for locally advanced and locally recurrent rectal cancer. J Contemp Brachyther. 2022;14(4):370\u20138.","journal-title":"J Contemp Brachyther."},{"issue":"6","key":"20398_CR13","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1177\/0962280215601873","volume":"26","author":"I Barrio","year":"2017","unstructured":"Barrio I, Arostegui I, Rodriguez-Alvarez MX, Quintana JM. A new approach to categorising continuous variables in prediction models: proposal and validation. Stat Methods Med Res. 2017;26(6):2586\u2013602.","journal-title":"Stat Methods Med Res."},{"issue":"4","key":"20398_CR14","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.ejso.2018.12.011","volume":"45","author":"JP Pennings","year":"2019","unstructured":"Pennings JP, de Haas RJ, Murshid KJA, de Jong KP, Dierckx R, Kwee TC. FDG-avid presacral soft tissue mass in previously treated rectal cancer: diagnostic outcome and additional value of MRI, including diffusion-weighted imaging. Eur J Surg Oncol. 2019;45(4):606\u201312.","journal-title":"Eur J Surg Oncol."},{"issue":"3","key":"20398_CR15","doi-asserted-by":"publisher","first-page":"zrab024","DOI":"10.1093\/bjsopen\/zrab024","volume":"5","author":"Z Rokan","year":"2021","unstructured":"Rokan Z, Simillis C, Kontovounisios C, Moran BJ, Tekkis P, Brown G. Systematic review of classification systems for locally recurrent rectal cancer. BJS Open. 2021;5(3):zrab024.","journal-title":"BJS Open."},{"issue":"1","key":"20398_CR16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1148\/radiol.10090725","volume":"256","author":"RC Dresen","year":"2010","unstructured":"Dresen RC, Kusters M, Daniels-Gooszen AW, Cappendijk VC, Nieuwenhuijzen GA, Kessels AG, et al. Absence of tumor invasion into pelvic structures in locally recurrent rectal cancer: prediction with preoperative MR imaging. Radiology. 2010;256(1):143\u201350.","journal-title":"Radiology."},{"issue":"11","key":"20398_CR17","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.1007\/s00261-019-02003-5","volume":"44","author":"D Ganeshan","year":"2019","unstructured":"Ganeshan D, Nougaret S, Korngold E, Rauch GM, Moreno CC. Locally recurrent rectal cancer: what the radiologist should know. Abdom Radiol (NY). 2019;44(11):3709\u201325.","journal-title":"Abdom Radiol (NY)."},{"issue":"6","key":"20398_CR18","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00261-022-03746-4","volume":"48","author":"A Inoue","year":"2023","unstructured":"Inoue A, Sheedy SP, Wells ML, Mileto A, Goenka AH, Ehman EC, et al. Rectal cancer pelvic recurrence: imaging patterns and key concepts to guide treatment planning. Abdom Radiol. 2023;48(6):1867\u201379.","journal-title":"Abdom Radiol."},{"issue":"7","key":"20398_CR19","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.ejrad.2016.04.006","volume":"85","author":"S Grosu","year":"2016","unstructured":"Grosu S, Schafer AO, Baumann T, Manegold P, Langer M, Gerstmair A. Differentiating locally recurrent rectal cancer from scar tissue: value of diffusion-weighted MRI. Eur J Radiol. 2016;85(7):1265\u201370.","journal-title":"Eur J Radiol."},{"issue":"11","key":"20398_CR20","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1007\/s00261-018-1518-z","volume":"43","author":"V Molinelli","year":"2018","unstructured":"Molinelli V, Angeretti MG, Duka E, Tarallo N, Bracchi E, Novario R, Fugazzola C. Role of MRI and added value of diffusion-weighted and gadolinium-enhanced MRI for the diagnosis of local recurrence from rectal cancer. Abdom Radiol. 2018;43(11):2903\u201312.","journal-title":"Abdom Radiol."},{"issue":"3","key":"20398_CR21","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.radi.2020.12.005","volume":"27","author":"R Javadrashid","year":"2021","unstructured":"Javadrashid R, Mahmoudpour M, Akhavi Milani A, Jalili J, Hajalioghli P, Nezami N. Value of diffusion-weighted images in diagnosis of locoregionally recurrent rectal tumors. Radiography. 2021;27(3):779\u201383.","journal-title":"Radiography."},{"issue":"6","key":"20398_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1007\/s00330-010-2052-8","volume":"21","author":"DM Lambregts","year":"2011","unstructured":"Lambregts DM, Cappendijk VC, Maas M, Beets GL, Beets-Tan RG. Value of MRI and diffusion-weighted MRI for the diagnosis of locally recurrent rectal cancer. Eur Radiol. 2011;21(6):1250\u20138.","journal-title":"Eur Radiol."},{"issue":"12","key":"20398_CR23","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.21037\/atm-21-2298","volume":"9","author":"Z Gao","year":"2021","unstructured":"Gao Z, Gu J. Surgical treatment of locally recurrent rectal cancer: a narrative review. Ann Transl Med. 2021;9(12):1026.","journal-title":"Ann Transl Med."},{"issue":"7","key":"20398_CR24","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1111\/j.1463-1318.2009.02167.x","volume":"13","author":"MB Nielsen","year":"2011","unstructured":"Nielsen MB, Laurberg S, Holm T. Current management of locally recurrent rectal cancer. Colorectal Dis. 2011;13(7):732\u201342.","journal-title":"Colorectal Dis."},{"issue":"10","key":"20398_CR25","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1002\/bjs.9569","volume":"101","author":"SJ Bosman","year":"2014","unstructured":"Bosman SJ, Holman FA, Nieuwenhuijzen GA, Martijn H, Creemers GJ, Rutten HJ. Feasibility of reirradiation in the treatment of locally recurrent rectal cancer. Br J Surg. 2014;101(10):1280\u20139.","journal-title":"Br J Surg."},{"issue":"1","key":"20398_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ejso.2016.08.015","volume":"43","author":"FA Holman","year":"2017","unstructured":"Holman FA, Bosman SJ, Haddock MG, Gunderson LL, Kusters M, Nieuwenhuijzen GA, et al. Results of a pooled analysis of IOERT containing multimodality treatment for locally recurrent rectal cancer: results of 565 patients of two major treatment centres. Eur J Surg Oncol. 2017;43(1):107\u201317.","journal-title":"Eur J Surg Oncol."},{"issue":"9","key":"20398_CR27","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1245\/s10434-020-08362-4","volume":"27","author":"ELK Voogt","year":"2020","unstructured":"Voogt ELK, van Zoggel D, Kusters M, Nieuwenhuijzen GAP, Bloemen JG, Peulen HMU, et al. Improved outcomes for responders after treatment with induction chemotherapy and chemo(re)irradiation for locally recurrent rectal cancer. Ann Surg Oncol. 2020;27(9):3503\u201313. https:\/\/doi.org\/10.1245\/s10434-020-08362-4.","journal-title":"Ann Surg Oncol."},{"issue":"7","key":"20398_CR28","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1093\/bjs\/znac083","volume":"109","author":"S Nordkamp","year":"2022","unstructured":"Nordkamp S, Voogt ELK, van Zoggel D, Martling A, Holm T, Jansson Palmer G, et al. Locally recurrent rectal cancer: oncological outcomes with different treatment strategies in two tertiary referral units. Br J Surg. 2022;109(7):623\u201331.","journal-title":"Br J Surg."},{"issue":"4","key":"20398_CR29","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/bjs.10694","volume":"105","author":"D van Zoggel","year":"2018","unstructured":"van Zoggel D, Bosman SJ, Kusters M, Nieuwenhuijzen GAP, Cnossen JS, Creemers GJ, et al. Preliminary results of a cohort study of induction chemotherapy-based treatment for locally recurrent rectal cancer. Br J Surg. 2018;105(4):447\u201352.","journal-title":"Br J Surg."},{"issue":"11","key":"20398_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.06.023","volume":"49","author":"LE Gould","year":"2023","unstructured":"Gould LE, Pring ET, Moorghen M, Burns EM, Antoniou A, Steele CW, et al. Pathological determinants of outcome following resection of locally advanced or locally recurrent rectal cancer. Eur J Surg Oncol. 2023;49(11):106971.","journal-title":"Eur J Surg Oncol."},{"issue":"4","key":"20398_CR31","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1245\/s10434-010-1435-z","volume":"18","author":"M Uemura","year":"2011","unstructured":"Uemura M, Ikeda M, Yamamoto H, Kitani K, Tokuoka M, Matsuda K, et al. Clinicopathological assessment of locally recurrent rectal cancer and relation to local re-recurrence. Ann Surg Oncol. 2011;18(4):1015\u201322. https:\/\/doi.org\/10.1245\/s10434-010-1435-z.","journal-title":"Ann Surg Oncol."},{"issue":"9","key":"20398_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.03.005","volume":"49","author":"JM van Rees","year":"2023","unstructured":"van Rees JM, Nordkamp S, Harmsen PW, Rutten H, Burger JWA, Verhoef C. Locally recurrent rectal cancer and distant metastases: Is there still a chance of cure? Eur J Surg Oncol. 2023;49(9):106865.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"20398_CR33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1111\/codi.15537","volume":"23","author":"ELK Voogt","year":"2021","unstructured":"Voogt ELK, van Zoggel D, Kusters M, Nieuwenhuijzen GAP, Cnossen JS, Creemers GJ, et al. Impact of a history of metastases or synchronous metastases on survival in patients with locally recurrent rectal cancer. Colorectal Dis. 2021;23(5):1120\u201331.","journal-title":"Colorectal Dis."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20398-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-026-20398-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:24:37Z","timestamp":1792207477000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-026-20398-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["20398"],"URL":"https:\/\/doi.org\/10.1245\/s10434-026-20398-6","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]},"assertion":[{"value":"12 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":1,"name":"Ethics","label":"Disclosure","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was reviewed and approved by the Medical Research Ethics Committees United \u2013 Nieuwegein (registration number AW23.041W23.008). The study was not subject to the Medical Research Involving Human Subjects Act. Written informed consent for participation was waived due to the retrospective nature of this study.","order":2,"name":"Ethics","label":"Ethics Approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}